Search

everythinglearnresearchcommunity

for

Search:↓

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

Platelet-rich plasma might help with skin aging, ulcers, and hair loss, but more research is needed to prove its effectiveness and safety.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

PRP treatment significantly increased hair density and thickness in male hair loss.

Using micrografts with stem cells and platelet-rich plasma can safely and effectively help regrow hair.

Fat transplants using a patient's own fat can rejuvenate and repair tissues effectively.

Platelet-rich plasma (PRP) may help promote hair growth and improve graft survival after hair transplantation, but more research is needed to confirm its effectiveness and determine the best dosage.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Exosome therapy shows promise for treating skin conditions and improving wound healing.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Platelet-rich plasma (PRP) is a promising treatment for hair loss, believed to extend the life cycle of hair follicles and prevent their shrinkage.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

Wnt1a-conditioned medium from stem cells helps activate cells important for hair growth and can promote hair regrowth.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

PRP injections can increase hair density in people with androgenic alopecia.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Epidermal stem cells help heal severe skin wounds and have potential for medical treatments.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.